Control of CAR-T cell activity in space and time: the next level of anti-tumor action

被引：0
|
作者：
Hoppstaedter, Jessica [1 ]
Kiemer, Alexandra K. [1 ]
机构：
[1] Saarland Univ, Dept Pharm, Pharmaceut Biol, Saarbrucken, Germany
来源：
SIGNAL TRANSDUCTION AND TARGETED THERAPY | 2023年 / 8卷 / 01期
关键词：
D O I：
10.1038/s41392-023-01424-5
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Inducible localized delivery of an anti-PD-1 scFv enhances anti-tumor activity of ROR1 CAR-T cells in TNBC
    Micaela Harrasser
    Satyen Harish Gohil
    Hiu Lau
    Marco Della Peruta
    Vincent Muczynski
    Dominic Patel
    Elena Miranda
    Kristiana Grigoriadis
    Anita Grigoriadis
    David Granger
    Rachel Evans
    Amit Chunilal Nathwani
    Breast Cancer Research, 24
  • [42] High expansion level and long term persistence of BCMA CAR-T cells contribute to potent anti-tumor activity against heavily treated multiple myeloma patients
    Hu, Yongxian
    Zhang, Yanlei
    Wei, Guoqing
    Xu, Huijun
    Wu, Wenjun
    Liu, Shaohui
    Cui, Jiazhen
    Chang, Alex Hongsheng
    Huang, He
    BONE MARROW TRANSPLANTATION, 2019, 54 : 37 - 38
  • [43] SYNTHETIC RE-DIRECTION OF TGFβ RECEPTORS AS A NOVEL STRATEGY TO ENHANCE THE ANTI-TUMOR ACTIVITY OF CAR-T CELLS IN SOLID TUMORS
    Peralta, Eigen
    Carron, Emily
    Chu, Hui-Yi
    Loter, Lorraine
    Navarrete, Natalie
    Tam, Arvin
    Mehta, Amit
    Lu, Dan
    Chu, Philip
    Lyon, Kenyon
    Pan, Yijia
    Pribadi, Mochtar
    Witty, Alec
    Lee, Tom
    Valamehr, Bob
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A147 - A147
  • [44] Rapid generation of CD19 CAR-T cells by minicircle DNA enables anti-tumor activity and prevents fatal CAR-B leukemia
    Ye, Xueshuai
    Wu, Yongqiang
    Zhang, c Haiqiang
    Shi, de Long
    Zhou, Ye
    Guo, Sumin
    Dong, Jiantao
    Cai, Jianhui
    CANCER LETTERS, 2023, 568
  • [45] HER2 TKIs enhance the anti-tumor activity of HER2-targeting CAR-T and CAR-NK cells against NSCLC
    Yang, Yan
    Nilsson, Monique B.
    Poteete, Alissa
    He, Junqin
    Huang, Qian
    Heymach, John V.
    CANCER RESEARCH, 2024, 84 (06)
  • [46] CAR-T Engager proteins optimize anti-CD19 CAR-T cell therapies for lymphoma
    Su, Lihe
    Wu, Lan
    Lobb, Roy R.
    Rennert, Paul D.
    Ambrose, Christine
    ONCOIMMUNOLOGY, 2022, 11 (01):
  • [47] CAR-T ENGAGER PROTEINS OPTIMIZE ANTI-CD19 CAR-T CELL THERAPIES FOR LYMPHOMA
    Rennert, Paul
    Su, Lihe
    Wu, Lan
    Lobb, Roy
    Ambrose, Christine
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A187 - A187
  • [48] CD72 Nanobody-Based CAR-T Cells Have Potent Anti-Tumor Efficacy in B Cell Malignancies
    Nix, Matthew A.
    Temple, William C.
    Karlon, William
    Wang, Donghui
    Phojanakong, Paul
    Steri, Veronica
    Hann, Byron
    Wiita, Arun P.
    BLOOD, 2021, 138
  • [49] Oncolytic Adenovirus Expressing Cytokines Enhances Anti-Tumor Efficacy of Mesothelin-Redirected CAR-T Cells
    Watanabe, Keisuke
    Guedan, Sonia
    Scholler, John
    McGettigan, Shannon
    Luo, Yangpin
    Tahtinen, Siri
    Parviainen, Suvi
    Havunen, Riikka
    Siurala, Mikko
    Hemminki, Akseli
    June, Carl H.
    BLOOD, 2016, 128 (22)
  • [50] NOVEL CAR-T CELLS TARGETING THE EXTRACELLULAR MATRIX OF GLIOBLASTOMA INDUCE STRONG ANTI-TUMOR IMMUNE RESPONSE
    Sengupta, Sadhak
    Mohan, Nandhu
    Chiocca, E. Antonio
    Sampath, Prakash
    Viapiano, Mariano
    NEURO-ONCOLOGY, 2016, 18 : 86 - 87
12345